Nephrology Clinical Trials

A Focal Segmental Glomerulosclerosis Clinical Trial in Miami is enrolling participants ages 12 years and older diagnosed with FSGS kidney disease, a condition that causes scarring in the kidney’s filtering units and can lead to protein in the urine, swelling, fatigue, and declining kidney function. This study evaluates an investigational drug to determine its efficacy in improving kidney health. The study is evaluating safety, tolerability, and overall effectiveness over time. Participants receive close medical supervision, regular health assessments, and ongoing support while contributing to research that may advance future treatment options.

An end-stage kidney disease clinical trial is enrolling adults with APOL1-genetic mutation that affects your overall kidney function. The study evaluates investigational treatments aimed at slowing disease progression, supporting kidney function, and improving quality of life.